Investigation announced for Investors in shares of Geron Corporation (NASDAQ: GERN)

Geron Corporation is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Geron Corporation (NASDAQ: GERN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Geron Corporation (NASDAQ: GERN) concerning whether a series of statements by Geron Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Menlo Park, CA based Geron Corporation, a clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for hematologic myeloid malignancies. Geron Corporation was developing imetelstat in partnership with Janssen Biotech Inc. ("Janssen"), a division of Johnson & Johnson. Imetelstat was intended to treat certain cancers that occur in bone marrow and the IMbark study was designed to ascertain whether imetelstat helped patients with a cancer called myelofibrosis.

On September 27, 2018, Geron Corporation announced that patients in the IMbark study had shown only 10% spleen response rate and 32% symptom response rate. Geron Corporation also announced that Janssen had terminated its partnership with the Geron for the development of imetelstat.

Shares of Geron Corporation (NASDAQ: GERN) declined from $6.23 per share on September 4, 2018 to as low as $0.95 per share in December 2018.

Those who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.